TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
GHN Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,023
|
280
|
5,963 |
Financial expenses |
11
|
2,304
|
308 |
Earnings before taxes |
5,359
|
-2,814
|
14,991 |
EBITDA |
-61
|
-1,905
|
-1,510 |
Total assets |
96,790
|
85,718
|
92,202 |
Current assets |
3,008
|
2,273
|
3,302 |
Current liabilities |
857
|
199
|
333 |
Equity capital |
95,933
|
85,519
|
91,870 |
- share capital |
417
|
390
|
402 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.1%
|
99.8%
|
99.6% |
Turnover per employee |
1,012
|
140
|
2,982 |
Profit as a percentage of turnover |
264.9%
|
-1005.0%
|
251.4% |
Return on assets (ROA) |
5.5%
|
-0.6%
|
16.6% |
Current ratio |
351.0%
|
1142.2%
|
991.6% |
Return on equity (ROE) |
5.6%
|
-3.3%
|
16.3% |
Change turnover |
1,723
|
-5,503
|
5,884 |
Change turnover % |
575%
|
-95%
|
7448% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.